APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Haemophilus Influenzae Type B Injection Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Haemophilus Influenzae Type B Injection Vaccine Market Outlook and Growth Opportunities 2026

Report ID 173996690430 December 2025193 pages

Choose your research edition.

Industry ResearchHaemophilus Influenzae Type B Injection Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Haemophilus Influenzae Type B Injection Vaccine Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Haemophilus Influenzae Type B Injection Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haemophilus Influenzae Type B Injection Vaccine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Haemophilus Influenzae Type B Injection Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Haemophilus Influenzae Type B Injection Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Haemophilus Influenzae Type B Injection Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Haemophilus Influenzae Type B Injection Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Haemophilus Influenzae Type B Injection Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Haemophilus Influenzae Type B Injection Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Haemophilus Influenzae Type B Injection Vaccine market include Bharat Biotech, Biokangtai, Glaxosmithkline, Olymvax, Sanofi Pasteur, Walvax Biotechnology, Beijing Minhai Biotechnology Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd and Chengdu Oulin Biotechnology Co., Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Haemophilus Influenzae Type B Injection Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Haemophilus Influenzae Type B Injection Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Haemophilus Influenzae Type B Injection Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Haemophilus Influenzae Type B Injection Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Haemophilus Influenzae Type B Injection Vaccine Segment by Company

Bharat Biotech

Biokangtai

Glaxosmithkline

Olymvax

Sanofi Pasteur

Walvax Biotechnology

Beijing Minhai Biotechnology Co., Ltd

Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd

Chengdu Oulin Biotechnology Co., Ltd

Chengdu Institute of Biological Products Co., Ltd

Lanzhou Institute of Biological Products Co., Ltd

Yuxi Watson Biotechnology Co., Ltd

Haemophilus Influenzae Type B Injection Vaccine Segment by Type

Lyophilized

Non-lyophilized

Haemophilus Influenzae Type B Injection Vaccine Segment by Application

Hospital

Clinic

Haemophilus Influenzae Type B Injection Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Haemophilus Influenzae Type B Injection Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Haemophilus Influenzae Type B Injection Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Haemophilus Influenzae Type B Injection Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Haemophilus Influenzae Type B Injection Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haemophilus Influenzae Type B Injection Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haemophilus Influenzae Type B Injection Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haemophilus Influenzae Type B Injection Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Haemophilus Influenzae Type B Injection Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Haemophilus Influenzae Type B Injection Vaccine industry.

Chapter 3: Detailed analysis of Haemophilus Influenzae Type B Injection Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Haemophilus Influenzae Type B Injection Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Haemophilus Influenzae Type B Injection Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Haemophilus Influenzae Type B Injection Vaccine Industry Trends Table 2. Haemophilus Influenzae Type B Injection Vaccine Industry Drivers Table 3. Haemophilus Influenzae Type B Injection Vaccine Industry Opportunities and Challenges Table 4. Haemophilus Influenzae Type B Injection Vaccine Industry Restraints Table 5. Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Haemophilus Influenzae Type B Injection Vaccine Revenue Share by Company (2021-2026) Table 7. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Haemophilus Influenzae Type B Injection Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Haemophilus Influenzae Type B Injection Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Haemophilus Influenzae Type B Injection Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Haemophilus Influenzae Type B Injection Vaccine Company, Product Type & Application Table 13. Global Haemophilus Influenzae Type B Injection Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Haemophilus Influenzae Type B Injection Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Lyophilized Table 18. Significant Companies of Non-lyophilized Table 19. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume Share by Application (2021-2026) Table 35. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume Share by Application (2027-2032) Table 36. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application (2021-2026) Table 40. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application (2027-2032) Table 41. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2021-2026) & (K Units) Table 43. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region (2021-2026) Table 44. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2027-2032) & (K Units) Table 45. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region (2027-2032) Table 46. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Region (2021-2026) Table 49. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Region (2027-2032) Table 51. Global Haemophilus Influenzae Type B Injection Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Haemophilus Influenzae Type B Injection Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026) & (K Units) Table 56. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2021-2026) Table 57. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032) & (K Units) Table 58. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Country (2027-2032) Table 59. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Market Share by Country (2021-2026) Table 61. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Market Share by Country (2027-2032) Table 63. Bharat Biotech Company Information Table 64. Bharat Biotech Business Overview Table 65. Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 67. Bharat Biotech Recent Development Table 68. Biokangtai Company Information Table 69. Biokangtai Business Overview Table 70. Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 72. Biokangtai Recent Development Table 73. Glaxosmithkline Company Information Table 74. Glaxosmithkline Business Overview Table 75. Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 77. Glaxosmithkline Recent Development Table 78. Olymvax Company Information Table 79. Olymvax Business Overview Table 80. Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Olymvax Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 82. Olymvax Recent Development Table 83. Sanofi Pasteur Company Information Table 84. Sanofi Pasteur Business Overview Table 85. Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 87. Sanofi Pasteur Recent Development Table 88. Walvax Biotechnology Company Information Table 89. Walvax Biotechnology Business Overview Table 90. Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 92. Walvax Biotechnology Recent Development Table 93. Beijing Minhai Biotechnology Co., Ltd Company Information Table 94. Beijing Minhai Biotechnology Co., Ltd Business Overview Table 95. Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 97. Beijing Minhai Biotechnology Co., Ltd Recent Development Table 98. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information Table 99. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview Table 100. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 102. Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Development Table 103. Chengdu Oulin Biotechnology Co., Ltd Company Information Table 104. Chengdu Oulin Biotechnology Co., Ltd Business Overview Table 105. Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 107. Chengdu Oulin Biotechnology Co., Ltd Recent Development Table 108. Chengdu Institute of Biological Products Co., Ltd Company Information Table 109. Chengdu Institute of Biological Products Co., Ltd Business Overview Table 110. Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 112. Chengdu Institute of Biological Products Co., Ltd Recent Development Table 113. Lanzhou Institute of Biological Products Co., Ltd Company Information Table 114. Lanzhou Institute of Biological Products Co., Ltd Business Overview Table 115. Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 117. Lanzhou Institute of Biological Products Co., Ltd Recent Development Table 118. Yuxi Watson Biotechnology Co., Ltd Company Information Table 119. Yuxi Watson Biotechnology Co., Ltd Business Overview Table 120. Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio Table 122. Yuxi Watson Biotechnology Co., Ltd Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Haemophilus Influenzae Type B Injection Vaccine Distributors List Table 126. Haemophilus Influenzae Type B Injection Vaccine Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Haemophilus Influenzae Type B Injection Vaccine Product Image Figure 2. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Haemophilus Influenzae Type B Injection Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Haemophilus Influenzae Type B Injection Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Haemophilus Influenzae Type B Injection Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Lyophilized Image Figure 10. Non-lyophilized Image Figure 11. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume Share by Application (2021-2032) Figure 22. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application (2021-2032) Figure 25. Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Haemophilus Influenzae Type B Injection Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Haemophilus Influenzae Type B Injection Vaccine Sales Value (2021-2032) & (US$ Million) Figure 30. North America Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Haemophilus Influenzae Type B Injection Vaccine Sales Value (2021-2032) & (US$ Million) Figure 36. South America Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Haemophilus Influenzae Type B Injection Vaccine Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Haemophilus Influenzae Type B Injection Vaccine Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Haemophilus Influenzae Type B Injection Vaccine Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Lyophilized
  • Non-lyophilized
Applications
  • Hospital
  • Clinic
Companies covered
  • Bharat Biotech
  • Biokangtai
  • Glaxosmithkline
  • Olymvax
  • Sanofi Pasteur
  • Walvax Biotechnology
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  • Chengdu Oulin Biotechnology Co., Ltd
  • Chengdu Institute of Biological Products Co., Ltd
  • Lanzhou Institute of Biological Products Co., Ltd
  • Yuxi Watson Biotechnology Co., Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Haemophilus Influenzae Type B Injection Vaccine Market Dynamics
  1. 2.1 Haemophilus Influenzae Type B Injection Vaccine Industry Trends
  2. 2.2 Haemophilus Influenzae Type B Injection Vaccine Industry Drivers
  3. 2.3 Haemophilus Influenzae Type B Injection Vaccine Industry Opportunities and Challenges
  4. 2.4 Haemophilus Influenzae Type B Injection Vaccine Industry Restraints
3 Haemophilus Influenzae Type B Injection Vaccine Market by Company
  1. 3.1 Global Haemophilus Influenzae Type B Injection Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Haemophilus Influenzae Type B Injection Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Haemophilus Influenzae Type B Injection Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Haemophilus Influenzae Type B Injection Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Haemophilus Influenzae Type B Injection Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Haemophilus Influenzae Type B Injection Vaccine Company Product Type and Application
  8. 3.8 Global Haemophilus Influenzae Type B Injection Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Haemophilus Influenzae Type B Injection Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Haemophilus Influenzae Type B Injection Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Haemophilus Influenzae Type B Injection Vaccine Market by Type
  1. 4.1 Haemophilus Influenzae Type B Injection Vaccine Type Introduction
  2. 4.1.1 Lyophilized
  3. 4.1.2 Non-lyophilized
  4. 4.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Type
  5. 4.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Type
  9. 4.3.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type (2021-2032)
5 Haemophilus Influenzae Type B Injection Vaccine Market by Application
  1. 5.1 Haemophilus Influenzae Type B Injection Vaccine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Application
  5. 5.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Application
  9. 5.3.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application (2021-2032)
6 Haemophilus Influenzae Type B Injection Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Haemophilus Influenzae Type B Injection Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Haemophilus Influenzae Type B Injection Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Haemophilus Influenzae Type B Injection Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Haemophilus Influenzae Type B Injection Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Haemophilus Influenzae Type B Injection Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Country, 2025 VS 2032
7 Haemophilus Influenzae Type B Injection Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Haemophilus Influenzae Type B Injection Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Haemophilus Influenzae Type B Injection Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Haemophilus Influenzae Type B Injection Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bharat Biotech
  2. 8.1.1 Bharat Biotech Company Information
  3. 8.1.2 Bharat Biotech Business Overview
  4. 8.1.3 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bharat Biotech Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  6. 8.1.5 Bharat Biotech Recent Developments
  7. 8.2 Biokangtai
  8. 8.2.1 Biokangtai Company Information
  9. 8.2.2 Biokangtai Business Overview
  10. 8.2.3 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Biokangtai Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  12. 8.2.5 Biokangtai Recent Developments
  13. 8.3 Glaxosmithkline
  14. 8.3.1 Glaxosmithkline Company Information
  15. 8.3.2 Glaxosmithkline Business Overview
  16. 8.3.3 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Glaxosmithkline Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  18. 8.3.5 Glaxosmithkline Recent Developments
  19. 8.4 Olymvax
  20. 8.4.1 Olymvax Company Information
  21. 8.4.2 Olymvax Business Overview
  22. 8.4.3 Olymvax Haemophilus Influenzae Type B Injection Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Olymvax Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  24. 8.4.5 Olymvax Recent Developments
  25. 8.5 Sanofi Pasteur
  26. 8.5.1 Sanofi Pasteur Company Information
  27. 8.5.2 Sanofi Pasteur Business Overview
  28. 8.5.3 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sanofi Pasteur Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  30. 8.5.5 Sanofi Pasteur Recent Developments
  31. 8.6 Walvax Biotechnology
  32. 8.6.1 Walvax Biotechnology Company Information
  33. 8.6.2 Walvax Biotechnology Business Overview
  34. 8.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  36. 8.6.5 Walvax Biotechnology Recent Developments
  37. 8.7 Beijing Minhai Biotechnology Co., Ltd
  38. 8.7.1 Beijing Minhai Biotechnology Co., Ltd Company Information
  39. 8.7.2 Beijing Minhai Biotechnology Co., Ltd Business Overview
  40. 8.7.3 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Beijing Minhai Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  42. 8.7.5 Beijing Minhai Biotechnology Co., Ltd Recent Developments
  43. 8.8 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
  44. 8.8.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Company Information
  45. 8.8.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Business Overview
  46. 8.8.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  48. 8.8.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments
  49. 8.9 Chengdu Oulin Biotechnology Co., Ltd
  50. 8.9.1 Chengdu Oulin Biotechnology Co., Ltd Company Information
  51. 8.9.2 Chengdu Oulin Biotechnology Co., Ltd Business Overview
  52. 8.9.3 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Chengdu Oulin Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  54. 8.9.5 Chengdu Oulin Biotechnology Co., Ltd Recent Developments
  55. 8.10 Chengdu Institute of Biological Products Co., Ltd
  56. 8.10.1 Chengdu Institute of Biological Products Co., Ltd Company Information
  57. 8.10.2 Chengdu Institute of Biological Products Co., Ltd Business Overview
  58. 8.10.3 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Chengdu Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  60. 8.10.5 Chengdu Institute of Biological Products Co., Ltd Recent Developments
  61. 8.11 Lanzhou Institute of Biological Products Co., Ltd
  62. 8.11.1 Lanzhou Institute of Biological Products Co., Ltd Company Information
  63. 8.11.2 Lanzhou Institute of Biological Products Co., Ltd Business Overview
  64. 8.11.3 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Lanzhou Institute of Biological Products Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  66. 8.11.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
  67. 8.12 Yuxi Watson Biotechnology Co., Ltd
  68. 8.12.1 Yuxi Watson Biotechnology Co., Ltd Company Information
  69. 8.12.2 Yuxi Watson Biotechnology Co., Ltd Business Overview
  70. 8.12.3 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Yuxi Watson Biotechnology Co., Ltd Haemophilus Influenzae Type B Injection Vaccine Product Portfolio
  72. 8.12.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Haemophilus Influenzae Type B Injection Vaccine Value Chain Analysis
  2. 9.1.1 Haemophilus Influenzae Type B Injection Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Haemophilus Influenzae Type B Injection Vaccine Sales Mode & Process
  6. 9.2 Haemophilus Influenzae Type B Injection Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Haemophilus Influenzae Type B Injection Vaccine Distributors
  9. 9.2.3 Haemophilus Influenzae Type B Injection Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst